Thought Leadership What Massachusetts biotech needs to know about FDA’s Expedited IND Pilot Oct 06, 2026
Thought Leadership “Undruggable” No More: Takeaways from MassBio’s 2026 Women’s Health Symposium on Pancreatic Cancer Oct 02, 2026
In the News MassBio in Banker & Tradesman: Why Real Estate Has to Be Part of Biotech’s Comeback Sep 29, 2026
Thought Leadership Termeer Ascend’s first cohort is already putting leadership into practice Sep 21, 2026
Policy & Advocacy Congressman Jake Auchincloss on Research Funding, FDA Reform, and U.S. Biotech Competitiveness Sep 02, 2026
Member Viewpoints A Biomarker Approach to Elucidate Immune Reset: Lessons for T Cell Engagers in Autoimmune Diseases Jun 09, 2026
Innovation Advanced Modalities: The Unglamorous Decisions That Determine Whether Your Program Moves Forward Jun 01, 2026
